MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6405-1239-1250$20.00
Mol Pharmacol 64:1239-1250, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robertson, D. N.
Right arrow Articles by Mitchell, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, D. N.
Right arrow Articles by Mitchell, R.

Selective Interaction of ARF1 with the Carboxy-Terminal Tail Domain of the 5-HT2A Receptor

Derek N. Robertson, Melanie S. Johnson, Louise O. Moggach, Pamela J. Holland, Eve M. Lutz, and Rory Mitchell

MRC Membrane and Adapter Proteins Cooperative Group, Membrane Biology Interdisciplinary Research Group, University of Edinburgh, School of Biomedical and Clinical Laboratory Sciences, Hugh Robson Building, George Square, Edinburgh, Scotland, United Kingdom (D.N.R., M.S.J., L.O.M., P.J.H., R.M.); Department of Bioscience & Biotechnology, University of Strathclyde, Glasgow, Scotland, United Kingdom (E.M.L.)

The 5-hydroxytryptamine 2A receptor (5-HT2AR) is a member of the class I family of rhodopsin-related G protein-coupled receptors. The receptor is known to activate phospholipase C via the heterotrimeric G proteins Gq/11, but we showed previously that it can also signal through the phospholipase D (PLD) pathway in an ADP-ribosylation factor (ARF)-dependent manner that seems to be independent of Gq/11 (Mitchell et al., 1998). Both coimmunoprecipitation experiments and the effects of negative mutant ARF constructs on 5-HT2AR-induced PLD activation here suggested that ARF1 may play a greater role than ARF6 in the function of this receptor. Furthermore, we demonstrated using glutathione S-transferase (GST)-fusion proteins of receptor domains that ARF1 and ARF6 bind to the third intracellular loop (i3) and the carboxy terminal tail (ct) of the 5-HT2AR. The association of ARF1 with the ct domain of the receptor was stronger than its interaction with i3, or the interactions of ARF6 with either construct. Experiments using ARF mutants that are deficient in GTP loading, and the in vitro addition of GTP{gamma}S suggested that GTP loading enhances ARF1 binding to the receptor. The N376PxxY motif in the transmembrane 7 domain of the receptor (rather than a N376DPxxY mutant form) was shown to be essential for ARF-dependent PLD signaling and ARF1 coimmunoprecipitation. In GST-fusion proteins of the 5-HT2AR ct domain, mutation of Asn376 to Asp also markedly reduced ARF1-HA binding, although additional motifs in the Asn376-Asn384 sequence and to a lesser extent elsewhere, seem also to contribute to the interaction.


Received August 6, 2003; accepted August 13, 2003

Address correspondence to: Rory Mitchell, MRC Membrane and Adapter Proteins Co-operative Group, Membrane Biology Interdisciplinary Research Group, University of Edinburgh, School of Biomedical and Clinical Laboratory Sciences, Hugh Robson Building, George Square, Edinburgh, Scotland, EH8 9XD, UK. E-mail: rory.mitchell{at}ed.ac.uk




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. A. Grodnitzky, N. Syed, M. J. Kimber, T. A. Day, J. G. Donaldson, and W. H. Hsu
Somatostatin Receptors Signal through EFA6A-ARF6 to Activate Phospholipase D in Clonal beta-Cells
J. Biol. Chem., May 4, 2007; 282(18): 13410 - 13418.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Deretic, A. H. Williams, N. Ransom, V. Morel, P. A. Hargrave, and A. Arendt
Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4)
PNAS, March 1, 2005; 102(9): 3301 - 3306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Houndolo, P.-L. Boulay, and A. Claing
G Protein-coupled Receptor Endocytosis in ADP-ribosylation Factor 6-depleted Cells
J. Biol. Chem., February 18, 2005; 280(7): 5598 - 5604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Turner, A. K. Gelasco, and J. R. Raymond
Calmodulin Interacts with the Third Intracellular Loop of the Serotonin 5-Hydroxytryptamine1A Receptor at Two Distinct Sites: PUTATIVE ROLE IN RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C
J. Biol. Chem., April 23, 2004; 279(17): 17027 - 17037.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. El Annan, D. Brown, S. Breton, S. Bourgoin, D. A. Ausiello, and V. Marshansky
Differential expression and targeting of endogenous Arf1 and Arf6 small GTPases in kidney epithelial cells in situ
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C768 - C778.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics